Ladue v. Secretary of Health and Human Services

United States Court of Federal Claims·Decided January 8, 2019·No. 12-553·Unpublished

Opinion

In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS No. 12-553V Filed: December 14, 2018 ` * * * * * * * * * * * * * * * NATHANIEL LADUE as the Parent and * UNPUBLISHED Natural Guardian of B.L., an infant, * * Petitioner, * Decision on Attorneys’ Fees and Costs; v. * Reasonable Basis; Overbilling * SECRETARY OF HEALTH * AND HUMAN SERVICES, * * Respondent. * * * * * * * * * * * * * * * *

Mark Sadaka, Esq., Mark T. Sadaka, LLC, Englewood, NJ, for petitioner. Darryl Wishard, Esq., U.S. Department of Justice, Washington, DC, for respondent.

DECISION ON ATTORNEYS’ FEES AND COSTS1

Roth, Special Master:

On August 30, 2012, Nathaniel Ladue (“Mr. Ladue,” or “petitioner”) filed a petition for compensation under the National Vaccine Injury Compensation Program2 on behalf of his minor child, B.L. Petitioner alleged that B.L. developed a seizure disorder after receiving human papillomavirus (“HPV”) vaccinations on September 22, 2010, and November 24, 2010. See Petition (“Pet.”), ECF No. 1. Petitioner further alleged that B.L.’s seizures were either caused-in- fact or significantly aggravated by the HPV vaccines. An entitlement hearing was held on February

1 Although this Decision has been formally designated “unpublished,” it will nevertheless be posted on the Court of Federal Claims’s website, in accordance with the E-Government Act of 2002, Pub. L. No. 107- 347, 116 Stat. 2899, 2913 (codified as amended at 44 U.S.C. § 3501 note (2006)). This means the Decision will be available to anyone with access to the internet. However, the parties may object to the Decision’s inclusion of certain kinds of confidential information. Specifically, under Vaccine Rule 18(b), each party has fourteen days within which to request redaction “of any information furnished by that party: (1) that is a trade secret or commercial or financial in substance and is privileged or confidential; or (2) that includes medical files or similar files, the disclosure of which would constitute a clearly unwarranted invasion of privacy.” Vaccine Rule 18(b). Otherwise, the whole Decision will be available to the public. Id.

2 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter, for ease of citation, all “§” references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C. § 300aa (2012).

1 27 and 28, 2017. On July 12, 2018 the undersigned issued a Decision denying entitlement to compensation and dismissing the petition. Decision, ECF No. 137.

I. Background

This matter was previously assigned to several special masters before ultimately being reassigned to me on October 21, 2015. ECF Nos. 2, 7, 11, 71.

Petitioner filed multiple expert reports from Dr. Marcel Kinsbourne, a pediatric neurologist, along with supporting medical literature. See Pet. Ex. 11, ECF No. 40; Pet. Ex. 32, ECF No. 68; Pet. Ex. 18-31, ECF Nos. 90-91; Pet. Ex. 37-38; ECF No. 102.

Respondent filed multiple expert reports from Dr. Shlomo Shinnar, along with supporting medical literature. See Resp. Ex. E-AA, ECF Nos. 49-51; Resp. Ex. BB-CC; ECF No. 58; Resp. Ex. DD-GG, ECF No. 61.

The parties were encouraged on multiple occasions by both myself and the Chief Special Master to explore an informal resolution to this matter. See Scheduling Order, ECF No. 53; Status Report Order, ECF No. 55; Status Report Order, ECF No. 69.

An entitlement hearing was originally scheduled for November 7 and 8, 2016, but due to a scheduling conflict was held on February 27 and 28, 2017. ECF Nos. 76, 83. Following the hearing, petitioner was ordered to file a number of additional records, including all medical records for B.L. dating from 1999 to 2008 and all testing and IEPs that had been prepared for B.L. since his diagnosis of autism at 18 months of age. Scheduling Order at 1-2, ECF No. 104. Petitioner was further ordered to file an affidavit clarifying references in the record to a family history of seizures. Id. Petitioner filed the requested records and affidavit in May and June of 2017. ECF Nos. 118, 120, 124.

Petitioner filed a Motion for Interim Attorneys’ Fees and Costs on May 10, 2017. ECF No. 112. Respondent filed a response on May 22, 2017, deferring to the special master to determine whether petitioner had met the standard for an award of interim fees and costs. Response at 2, ECF No. 113. Respondent stated that he was “satisfied that the statutory and other legal requirements for an award of attorneys’ fees and costs” had been met. Id. A decision was issued on May 25, 2017, awarding petitioner $79,460.95 in interim attorneys’ fees and costs. ECF No. 115.

Post-hearing briefs were filed in September and October of 2017. ECF Nos. 128, 132.

A status conference was held on April 3, 2018, during which I highlighted the strengths and weaknesses of the parties’ respective experts. Scheduling Order, ECF No. 135. I also asked the parties to consider the possibility of settling this matter. Id. Respondent filed a status report on April 6, 2018, indicating that he was not amenable to settlement. ECF No. 136.

An entitlement decision was issued on July 12, 2018, finding that petitioner had not demonstrated by a preponderance of the evidence that B.L.’s seizure disorder was caused or

2 significantly aggravated by his HPV vaccinations. See Decision, ECF No. 137. The petition was dismissed.

On November 26, 2018, petitioner filed a Motion for Attorneys’ Fees and Costs. Motion for Fees, ECF No. 141. Petitioner requests attorneys’ fees in the amount of $15,020.52 and attorneys’ costs in the amount of $23,670.37, for a total amount of $38,690.89. Id. at 3. In accordance with General Order #9, petitioner’s counsel represents that petitioner did not incur any out-of-pocket expenses. ECF No. 143.

On November 27, 2018, respondent filed a response to petitioners’ Motion for Fees. Response, ECF No. 142. Respondent deferred to the special master “to determine whether the statutory requirements for an award of attorneys’ fees and costs (including the reasonable basis requirement) are met in this case.” Id. at 2. Petitioner did not file a reply.

This matter is now ripe for decision.

II. Discussion

A. Good Faith and Reasonable Basis

The Vaccine Act permits an award of “reasonable attorneys’ fees” and “other costs.” § 15(e)(1). If a petitioner succeeds on the merits of his or her claim, the award of attorneys’ fees is automatic. Id.; see Sebelius v. Cloer, 133 S. Ct. 1886, 1891 (2013). However, a petitioner need not prevail on entitlement to receive a fee award as long as the petition was brought in “good faith” and there was a “reasonable basis” for the claim to proceed. § 15(e)(1).

Reasonable basis is typically viewed as “an objective standard determined by the ‘totality of the circumstances.’” Chuisano v. United States, 116 Fed. Cl. 276, 286 (2014) (citations omitted). It does not look to the “likeliness of success but more to the feasibility of the claims.” Id. at 285. “This totality of the circumstances assessment should take into account evidence available at the time a claim is filed and evidence that becomes available as the case progresses.” Cottingham v. Sec’y of Health & Human Servs., 2017 WL 4546579, at *7 (Fed. Cl. 2017). Accordingly, a case may have a reasonable basis when filed, but may lose reasonable basis during the pendency of the case.

Free access — add to your briefcase to read the full text and ask questions with AI

Ladue v. Secretary of Health and Human Services, (uscfc 2019).

Ladue v. Secretary of Health and Human Services (Ladue v. Secretary of Health and Human Services) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related